Essential Dynamics of CB1 Receptor-Agonist Complexes: Implications for Signalling Bias
Fellner, D. M. J.; Glass, M.; Furkert, D. P.
Show abstract
The CB1 cannabinoid receptor is implicated in a broad range of physiological processes and disease states, however CB1-targeting drugs in clinical use remain based on tetrahydrocannabinol (THC). Ligands that exhibit functional selectivity for different intracellular signalling pathways are currently an area of rapid development, and hold significant potential as therapeutic agents. Improved understanding of the exact molecular mechanisms underpinning biased activation of intracellular effector proteins for CB1 is necessary to enable drug development of biased CB1 ligands into candidates for treatment of human disease. Using molecular dynamics, this study shows that CB1conformations resulting from activation by the orthosteric ligands CP55940, {Delta}9-THC or 5F-MDMB-PICA exhibit differences in the dynamic organisation of key residues and receptor substructures involved in coupling to G proteins and {beta}-arrestins, that leads to selective activation of downstream signalling pathways. The identification of conformationally distinct CB1-agonist complexes that demonstrate different functional profiles provides an important step in unravelling the molecular determinants for biased signalling, and lays a platform for future rational design of novel therapeutic leads.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Structural Models for a Series of Allosteric Inhibitors of IGF1R Kinase 92%
- Single nucleotide polymorphism induces divergent dynamic patterns in CYP3A5: a microsecond scale biomolecular simulation of variants identified in Sub-Saharan African populations 92%
- The molecular mechanism of positive allosteric modulation at the dopamine D1 receptor 92%
Similar papers in this journal
- Molecular and functional characterization of buffalo nasal epithelial odorant binding proteins and their structural insights by in-silico and biochemical approach 92%
- A strategy to optimize the peptide-based inhibitors against different mutants of the spike protein of SARS-CoV-2 92%
- Structural analysis and ensemble docking revealed the binding modes of selected progesterone receptor modulators 91%
Similar papers in this journal
- Structural Insights into Dopamine Receptor-Ligand Interactions: From Agonists to Antagonists 94%
- A subtle structural modification of a synthetic cannabinoid receptor agonist drastically increases its efficacy at the CB1 receptor 94%
- Binding and activation of serotonergic G-protein coupled receptors by the multimodal antidepressant vortioxetine. 93%
Similar papers in this journal
- Molecular dynamics study of differential effects of serotonin-2A-receptor (5-HT2AR) modulators 95%
- Conformational plasticity and dynamic interactions of the N-terminal domain of the chemokine receptor CXCR1 93%
- In silico prediction of ARB resistance: A first step in creating personalized ARB therapy 93%
Similar papers in this journal
- Pharmacological Characterisation of Novel Adenosine Receptor A3R Antagonists 94%
- S494 O-glycosylation site on the SARS-COV-2 RBD Affects the Virus Affinity to ACE2 and its Infectivity; A Molecular Dynamics Study 92%
- The Hidden Potential of PDE4 Inhibitor Rolipram: A Multifaceted Examination of its Inhibition of MMP2/9 Reveals Therapeutic Implications 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.